Stock BALPHARMA BAL PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Bal Pharma Limited NSE India S.E.

Equities

BALPHARMA

INE083D01012

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:40:47 2024-04-29 am EDT 		5-day change 1st Jan Change
100.4 INR +0.15% Intraday chart for Bal Pharma Limited +2.81% +0.40%
Feb. 12 Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Bal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Business Summary

Bal Pharma Limited is a fully integrated pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It is specialized in bulk actives, prescription drugs, generics and pharma intermediates. Its focused therapeutic areas are anti-diabetes, anti-histamine, anti-inflammatory, acne treatment, gastroenterology, cardiology, and dermatology. It offers a range of APIs, which includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment. Its finished formulation products cover dosage forms, such as tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments. The Company offers a range of natural medicine, which includes ANARSHA, ASHWAMED, AYURFINE, AYURFINE FORTE, AYURSULIN, IMMUWIN, LIPIVED, MENOLEAP CAPSULES, MENOLEAP SYRUP, PROLIFE, and BALPRO SYRUP.

Number of employees: 869

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical Formulations and Active Pharmaceutical Ingredients
99.1 %
2,797 99.5 % 3,016 99.1 % +7.83%
Other
0.8 %
15 0.5 % 25 0.8 % +65.54%
Services
0.0 %
0 0.0 % 1 0.0 % +5,385.71%

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
2,812 100.0 % 3,042 100.0 % +8.18%

Managers

Managers TitleAgeSince
Shailesh Dheerajmal Siroya CEO
 Chief Executive Officer - 94-07-31
Daddanala Bharath Bhushan DFI
 Director of Finance/CFO - 23-06-01
Abdul Basith CMP
 Compliance Officer - 23-07-16
M. P. George COO
 Chief Operating Officer - 12-05-09

Members of the board

Members of the board TitleAgeSince
Shailesh Dheerajmal Siroya CEO
 Chief Executive Officer - 94-07-31
C. V. Srinivas BRD
 Director/Board Member 58 19-06-28
Himesh Virupakshaya BRD
 Director/Board Member - 19-09-27
H. S. Venkatesh BRD
 Director/Board Member - 20-05-22
Nicola Neeladri BRD
 Director/Board Member - 20-05-22
Jatish Sheth BRD
 Director/Board Member - 20-12-27
Kotian Chittananda Damodar BRD
 Director/Board Member 62 22-05-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,804,372 5,327,032 ( 33.71 %) 0 33.71 %

Company contact information

Bal Pharma Ltd.

Lakshmi Narayan Complex 10/1, Palace Road

560052, Bangalore

+91 80 4137 9500

http://www.balpharma.com
address Bal Pharma Limited(BALPHARMA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 332B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-4.04% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BALPHARMA Stock
  4. BALPHARMA Stock
  5. Company Bal Pharma Limited